GSK Acquires Aiolos Bio for US$1.4 B
By Amit Kaushik
Pharma Deals Review: Vol 2024 Issue 1 (Table of Contents)
Published: 31 Jan-2024
DOI: 10.3833/pdr.v2024.i1.2849 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In an attempt to bolster its respiratory portfolio, GSK has agreed to acquire Aiolos Bio for US$1 B upfront and up to US$400 M in potential development milestones...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS